CD44 and non-small cell lung carcinoma: Consistent with a mesenchymal phenotype, the NSCLC CDX expressed low levels of epithelial genes EPCAM and KRT8, high levels of mesenchymal genes vimentin and S100A4 [11], and a high ratio of CD44:CD24 [10].